Results from pooled Phase III studies of ulipristal acetate for emergency contraception

Caroline Moreau, James Trussell

Research output: Contribution to journalArticle

Abstract

Background: Ulipristal acetate (UPA) is a new effective option to prevent unintended pregnancies up to 5 days after unprotected intercourse. We used pooled data from two Phase III studies to refine our understanding of the efficacy of UPA by time from unprotected intercourse and the effects of other factors on pregnancy rates. Study Design: Data from two Phase III studies were pooled to create a larger analysis population. Analyses were performed on the first participation of 2183 women. Results: A total of 41 women became pregnant despite the use of UPA, yielding an overall proportion pregnant of 1.9% (1.3%-2.5%). Proportions of pregnant women were higher among those with further acts of unprotected intercourse in the same cycle and among obese women. These varied from 1.3% (0.9%-2.0%) among nonobese women who had no further acts of unprotected intercourse (n= 1704) to 8.3% (0.2%-38.5%) among obese women who had subsequent unprotected intercourse (n= 12). Conclusions: UPA is effective and safe in preventing pregnancy after unprotected intercourse. Its effectiveness is lower among women who have subsequent unprotected intercourse and among obese women.

Original languageEnglish (US)
Pages (from-to)673-680
Number of pages8
JournalContraception
Volume86
Issue number6
DOIs
StatePublished - Dec 2012
Externally publishedYes

Fingerprint

Postcoital Contraception
Pregnant Women
Pregnancy
Pregnancy Rate
ulipristal acetate
Population

Keywords

  • Efficacy
  • Emergency contraception
  • Obesity
  • Selective progesterone receptor modulator

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Results from pooled Phase III studies of ulipristal acetate for emergency contraception. / Moreau, Caroline; Trussell, James.

In: Contraception, Vol. 86, No. 6, 12.2012, p. 673-680.

Research output: Contribution to journalArticle

@article{119c8bf8aacf419f8f29e5a2073aaba7,
title = "Results from pooled Phase III studies of ulipristal acetate for emergency contraception",
abstract = "Background: Ulipristal acetate (UPA) is a new effective option to prevent unintended pregnancies up to 5 days after unprotected intercourse. We used pooled data from two Phase III studies to refine our understanding of the efficacy of UPA by time from unprotected intercourse and the effects of other factors on pregnancy rates. Study Design: Data from two Phase III studies were pooled to create a larger analysis population. Analyses were performed on the first participation of 2183 women. Results: A total of 41 women became pregnant despite the use of UPA, yielding an overall proportion pregnant of 1.9{\%} (1.3{\%}-2.5{\%}). Proportions of pregnant women were higher among those with further acts of unprotected intercourse in the same cycle and among obese women. These varied from 1.3{\%} (0.9{\%}-2.0{\%}) among nonobese women who had no further acts of unprotected intercourse (n= 1704) to 8.3{\%} (0.2{\%}-38.5{\%}) among obese women who had subsequent unprotected intercourse (n= 12). Conclusions: UPA is effective and safe in preventing pregnancy after unprotected intercourse. Its effectiveness is lower among women who have subsequent unprotected intercourse and among obese women.",
keywords = "Efficacy, Emergency contraception, Obesity, Selective progesterone receptor modulator",
author = "Caroline Moreau and James Trussell",
year = "2012",
month = "12",
doi = "10.1016/j.contraception.2012.05.012",
language = "English (US)",
volume = "86",
pages = "673--680",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Results from pooled Phase III studies of ulipristal acetate for emergency contraception

AU - Moreau, Caroline

AU - Trussell, James

PY - 2012/12

Y1 - 2012/12

N2 - Background: Ulipristal acetate (UPA) is a new effective option to prevent unintended pregnancies up to 5 days after unprotected intercourse. We used pooled data from two Phase III studies to refine our understanding of the efficacy of UPA by time from unprotected intercourse and the effects of other factors on pregnancy rates. Study Design: Data from two Phase III studies were pooled to create a larger analysis population. Analyses were performed on the first participation of 2183 women. Results: A total of 41 women became pregnant despite the use of UPA, yielding an overall proportion pregnant of 1.9% (1.3%-2.5%). Proportions of pregnant women were higher among those with further acts of unprotected intercourse in the same cycle and among obese women. These varied from 1.3% (0.9%-2.0%) among nonobese women who had no further acts of unprotected intercourse (n= 1704) to 8.3% (0.2%-38.5%) among obese women who had subsequent unprotected intercourse (n= 12). Conclusions: UPA is effective and safe in preventing pregnancy after unprotected intercourse. Its effectiveness is lower among women who have subsequent unprotected intercourse and among obese women.

AB - Background: Ulipristal acetate (UPA) is a new effective option to prevent unintended pregnancies up to 5 days after unprotected intercourse. We used pooled data from two Phase III studies to refine our understanding of the efficacy of UPA by time from unprotected intercourse and the effects of other factors on pregnancy rates. Study Design: Data from two Phase III studies were pooled to create a larger analysis population. Analyses were performed on the first participation of 2183 women. Results: A total of 41 women became pregnant despite the use of UPA, yielding an overall proportion pregnant of 1.9% (1.3%-2.5%). Proportions of pregnant women were higher among those with further acts of unprotected intercourse in the same cycle and among obese women. These varied from 1.3% (0.9%-2.0%) among nonobese women who had no further acts of unprotected intercourse (n= 1704) to 8.3% (0.2%-38.5%) among obese women who had subsequent unprotected intercourse (n= 12). Conclusions: UPA is effective and safe in preventing pregnancy after unprotected intercourse. Its effectiveness is lower among women who have subsequent unprotected intercourse and among obese women.

KW - Efficacy

KW - Emergency contraception

KW - Obesity

KW - Selective progesterone receptor modulator

UR - http://www.scopus.com/inward/record.url?scp=84869088736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869088736&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2012.05.012

DO - 10.1016/j.contraception.2012.05.012

M3 - Article

C2 - 22770793

AN - SCOPUS:84869088736

VL - 86

SP - 673

EP - 680

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 6

ER -